NEWSLETTER March 2017

to advance education and research in the science of www.bap.org.uk for the public benefit

INSIDE 1–2 Jeff Nye Obituary 3–4 2017 BAP Elections 5 Prof David Nutt Receives Honorary Doctorate from the University of Bath; Prof Trevor Robbins to Recieve SOBP’s 2017 Gold Medal Award; In Vivo Awards 6–7 Summer Meeting 2017 8 Launch of BAP Early Career Membership; Launch of the anti-dementia Guidelines; BAP Consensus Guideline Statements; Buddy Scheme at the 2017 Summer Meeting 9 BAP Session at the BNA Meeting; Summer Meeting Archive; Brain imaging study of cannabis dependence; BAP at the 2017 Cheltenham Science Festival 10–11 BOOK REVIEW: My Brain is Out of Control 12 Media Activities 13–14 Education Events

Jeff Nye Obituary With deepest sorrow, we mourn the untimely passing of our friend and esteemed colleague, British Association for Jeffrey S. Nye, MD, Psychopharmacology PhD, Vice President, 36 Cambridge Place Neuroscience Innovation Hills Road and Scientific Partnership Cambridge Strategy, Johnson & CB2 1NS Johnson Innovation. He 01223 358 395 was 57 years old. Jeff was a brilliant neurologist Executive Officer Susan Chandler • [email protected] and neuroscientist and a highly respected academic. It is hard to fathom the Assistant to the Executive Officer Lynne Harmer • [email protected] magnitude of this loss to our community. All of us who were lucky enough to have worked with Jeff know Online Resources and Communications Developer he represented the finest ideals in science. He was Sarah Channing-Wright • [email protected] extraordinarily dedicated, passionate about his work, intelligent, and curious. Jeff always pushed forward For m @BAPsych in the quest to learn more and to share all that was discovered. He led the formation of many productive BritishAssociationforPsychopharmacology continued on page 2 /company/britishassociationforpsychopharmacology The British Association for Psychopharmacology is registered in England +BapOrgUk as a Private Company No 5866899. Registered Charity No 277825. continued from page 1 scientific collaborations with universities and We were very lucky to have Jeff serve as a Co-opted research consortia, and advocated for advancement Member of the BAP Council from 2012–2015. In of science in academia through many sponsorships addition to enjoying his dry wit and humour, Jeff’s and philanthropy. Jeff previously held several roles at industry perspective proved valuable when planning the Janssen Pharmaceutical Companies of Johnson BAP events. He took part in a number of BAP & Johnson, including Chief Medical Officer of the symposia over the years and was also a member of East Coast Research and Early Development unit, the panel of the inaugural BAP Plenary Mental Health Vice President of Experimental Medicine, and Vice Session in 2011 “Mental health, neuroscience and the President of CNS Development. His professional life wellbeing of society”. was marked by tireless service to the larger scientific –– Susan Chandler, BAP Office community, by a desire to ask and answer important scientific questions and, above all, to make areal I knew Jeff through his many impressive difference with his research. He was honored with contributions to science and to scientific societies, numerous awards recognizing his scientific acumen including the BAP. He was always enthusiastic about and his dedication to improving the health of people research and keen to discuss new findings. I had worldwide. Jeff will be missed most acutely by his the pleasure of working with Jeff on several projects loving family but also by his many admiring colleagues, and we also co-authored articles together. During both here at Janssen and at Johnson & Johnson and in this time, I had the opportunity to find out what a the larger neuroscience community. We have lost an thoughtful, warm, friendly and kind person he was. important and beloved family member. We express He was also a devoted family man. I will greatly miss our deep sympathy to his beloved wife, Miriam our wonderful discussion on a wide range of topics, Chaloff, his sons, Maxwell and Leo Nye, his extended including neuroethics. One of my favourite memories family, and all of his friends and loved ones. We will is the day that he, Alan Frazer and I went sightseeing miss Jeff very much. around Tokyo after a CINP Meeting in 2015. We had a fabulous afternoon with lots of laughs! In my –– William N. Hait, Global Head, Janssen Research & lounge at home is the photo of the three of us at the Development top of Tokyo Tower, with an amazing view of the City Husseini K. Manji, Global Head, Neuroscience Therapeutic behind us – It always makes me smile. Area, Janssen Research & Development –– , BAP President 2012-2014 Robert Urban, Head, Johnson & Johnson Innovation, Boston Published in The New York Times on Mar. 8, 2017

For those who may wish to make a donation to Johns Hopkins in honor of Jeff Nye, please use the following link and instructions to donate electronically: https://secure.jhu.edu/form/somt Once you are in the form, Step 2 offers a drop down box with various funds; The Solomon H. Snyder Fund for MD-PhD Education and Research Training is listed.

2 March 2017 2017 Election for BAP Officers The following vacancies will arise on BAP Council in July: and Council Members Honorary General Secretary The main role of Council members is to represent Dr Maxine Patel ends her 3-year term the views of the membership and use their expertise to help shape BAP policies and activities. There are three Council meetings each year, two in London Secretary for Non-Clinical External Affairs and a third meeting held on the first day of the Dr Paula Moran ends her 3-year term Summer Meeting. These meetings are extremely important to the running of BAP. Over the course Two Elected Council Member posts of the year set agenda items include the planning the summer meeting, reviewing the Association’s (Post 1) Dr Sarah Bailey will retire finances and membership, liaison with outside (Post 2) Dr James Stone will retire bodies and public engagement, updating the BAP’s preclinical and clinical teaching programmes and Nominations are invited from Full, Early Career, assessing the progress of the two BAP journals, Honorary or Retired Full Members for the above Journal of Psychopharmacology and Therapeutic posts and should be supported by two Full, Early Advances in Psychopharmacology. The lead in many Career, Honorary or Retired Full Members. Separate of these areas is taken by the BAP’s Elected Officers emails should be sent to Susan Chandler from the supported by the BAP’s administrative office. Proposer, Seconder and Nominee, to arrive no later However the Officers very much rely on the Council than MONDAY 8 MAY. members to assist and guide them. There is much Voting will be online via the website only from scope for Council members to take on additional Monday 15 May and will close on MONDAY 3 JULY. responsibility for certain areas of work and join sub- The results will be announced at the Annual General committees. The work of a Council member involves Meeting on Monday 24 July in Harrogate. a lot of work but is also very rewarding and a lot of The BAP aims to represent the interests of all fun. You have the opportunity to influence the work psychopharmacologists. Council asks Members to bear this of BAP, represent your colleagues and meet a lot of in mind when making nominations for the election, to ensure great people. Being a Council member is not a pre- a balance of expertise. Please refer to the BAP Equality and requisite to stand for election to an Officer position Diversity Statement www.bap.org.uk/equality.php but in reality the responsibility and experience needed to fulfil an Officer post means that most of those who have been elected to Officer positions have Nominees had experience of serving on Council. If anyone is All nominees must provide a mini-biography, head- interested in standing as a Council Member and and-shoulders photograph and statement of intent would like more information I would encourage by THURSDAY 11 MAY. them to contact either myself or Susan Chandler for an informal discussion. Secretaries serve a 4-year term Maxine Patel, General Secretary Council Members serve a 4-year term. Council Meetings Three each year: March (London, full day), July (Sunday morning in association with the Summer Meeting), October/November (London, full afternoon).

March 2017 3 Expenses b) Council members will be informed if no nominations have been received by the deadline Council Members do not receive payment for and, if they wish, give names of people whom anything they do for the BAP. BAP will reimburse they consider suitable for the Nominations Sub- standard travel expenses and hotel accommodation Committee to consider if Council members are unable to cover these from an alternative source. c) The Nominations Sub-Committee will comprise the current Past-President, President, President- The following procedure will be implemented elect and one of the Secretaries if necessary: a) In the event of no nomination/s being received by the closing date, the Nominations Sub- Committee should find at least one person to be asked to put their name forward for election

Current Officers and Council See website for biographies www.bap.org.uk/council

ELECTED OFFICERS ELECTED COUNCIL MEMBERS

Professor Jo Neill Dr Sarah Bailey (Post 1) President

Professor Allan Young Dr James Stone (Post 2) President-Elect Dr Carmine Pariante (Post 3) Professor Paul Harrison Past-President Dr Rachel Upthegrove (Post 4) (filling a casual vacancy until July 2018) Dr Elizabeth Tunbridge Honorary Treasurer Professor Ciara McCabe (Post 5)

Dr Mitul Mehta Dr Peter Talbot (Post 6) Meetings Secretary

Dr Maxine Patel Dr Paul Stokes (Post 7) Honorary General Secretary Dr Angela Roberts (Post 8) Professor Jeremy Hall Secretary for Clinical External Affairs OTHER VOTING MEMBERS OF COUNCIL Dr Paula Moran Secretary for Non-Clinical External Affairs Jonas Eberhard

4 March 2017 Professor David Nutt Receives Honorary Doctorate from the University of Bath Sarah Bailey Prof David Nutt, BAP’s lifetime achievement winner 2016, was recently awarded his first ever honorary doctorate. In December 2016, David was awarded the degree of Doctor of Laws honoris causa by the University of Bath. David was nominated for the Prof David Nutt and his wife, Di, with members of the Department award by Prof Steve Husbands in the Department of Pharmacy and Pharmacology at the University of Bath. of Pharmacy and Pharmacology. Alongside © IDPS, University of Bath 2016 David’s psychopharmacology research, the award Left to right: Prof Steve Husbands, Mrs Di Nutt, Prof David Nutt, Dr Sarah recognized his commitment to using scientific Bailey, Dr Chris Bailey evidence to direct policy decisions and also his enthusiasm for communicating science to the “It was a great honour and privilege to receive this honour, public. As a local, born in Keynsham near Bath, particularly from the University of Bath because of its David was delighted to be honoured in this way. continued research commitment to psychopharmacology”.

Professor Trevor Robbins to Recieve Society of Biological Psychiatry’s 2017 Gold Medal Award Past President, Professor Trevor Robbins has been awarded the Society’s Gold Medal for his fundamental contributions to the understanding of cortico-striatal function and its role in many psychiatric disorders and addictions, as well as his work bridging mechanisms of pathology to new treatments. This award is given for lifetime achievement in advancing our understanding and treatment of psychiatric illness. Professor Robbins will be presented with the award at the Society’s 72nd Annual Scientific Convention and Meeting in San Diego, May 2017.

In Vivo Awards The In Vivo Training Awards were relaunched in autumn 2016, to provide significant support to BAP Members undertaking research. We were pleased to receive 7 strong applications and Awards have been made to Dr Marie-Christine Pardon (Nottingham) and Dr Nisha Singh (King’s College London).

March 2017 5 Harrogate International Centre Harrogate International Centre King’s Road, Harrogate Kings Road, Harrogate Sunday 23rd to Wednesday 26th July 2017 Sunday 23rd to Wednesday 26th July 2017

Highlights Applied Clinical Science Stream 9 invited symposia covering cutting-edge clinical and non-clinical Depression: Which treatment and for whom psychopharmacology: BAP is pleased to announce that our 2017 summer meeting will include an “Applied Clinical Science” stream. This stream is of particular relevance to trainees, staff ʍ Personalized pharmacological treatments for depression: grade and consultant psychiatrists and mental health pharmacists. In addition to providing Will big data achieve what clinicians can’t? high quality up-to-date psychopharmacology CPD for clinicians, the stream will highlight ʍ The psychopharmacology of emerging calcium channel targets insights into future developments in our understanding of mental illness and its treatment. ʍ Behavioural and substance addictions: Similarities and differences ʍ Adverse and beneficial effects of cannabinoids - new insights from genetics and clinical trials Treatment options for treatment resistant depression ʍ The role of brain connectivity in brain disorders and their treatment ʍ Psychopharmacology of the older and, almost certainly, degenerating brain ʍ Treatment of dysfunction in hot and cold cognition in mood disorders Sunday 23 July 12:00 – 16:45 ʍ The brain-gut axis: Breaking the dichotomy between physical and mental health Queen’s Suite 1 ʍ Biomarkers of treatment response for and bipolar affective disorder: Latest updates Chair – Allan Young, King’s College London PLUS 12:00 Lunch Launch of the Applied Clinical Science Stream (ACSS). Providing high quality up-to-date 13:00 – 13:15 Introduction psychopharmacology CPD for clinicians, the ACSS will highlight insights into future developments in our Allan Young, King’s College London understanding of mental illness and its treatment. The 2017 ACSS has the theme of ‘Depression: Which treatment and for whom’ 13:15 – 13:45 ‘Standard’ medication options and when should non-standard options be considered? Guest Lecture presented by Professor Sir Robin Murray Hamish McAllister-Williams, Newcastle University Facts about psychosis that (most) psychopharmacologists prefer to ignore 13:45 – 14:05 Medications targeting dopaminergic neurotransmission Preclinical Workshop Alan Currie, Newcastle University How can we refine preclinical psychopharmacology? 14:05 – 14:25 Running a ketamine treatment service in the NHS Trainees’ Workshop Rupert McShane, University of Oxford This year the overarching theme will be “How to …” 14:25 – 14:45 Q&A with the Panel Post-Doc Symposium 14:45 – 15:15 Refreshments Treatments in depression - new insights for an ongoing problem 15:15 – 15:35 tDCS Short Orals, Satellite Symposia and Special Sessions, Poster Sessions (posters also included on large Cindy Fu, King’s College London interactive screens) 15:35 – 15:55 TMS Welcome Reception and Disco Michael Craig, King’s College London 15:55 – 16:15 VNS Conference Dinner at The Royal Hall John Rush, Duke University An app will be available with full details of the programme and abstract book. 16:15 – 16:45 Q&A with the Panel 16:45 Refreshments www.bap.org.uk/BAP2017 6 March 2017 www.bap.org.uk/BAP2017 Harrogate International Centre Kings Road, Harrogate Sunday 23rd to Wednesday 26th July 2017 Applied Clinical Science Stream Depression: Which treatment and for whom BAP is pleased to announce that our 2017 summer meeting will include an “Applied Clinical Science” stream. This stream is of particular relevance to trainees, staff grade and consultant psychiatrists and mental health pharmacists. In addition to providing high quality up-to-date psychopharmacology CPD for clinicians, the stream will highlight insights into future developments in our understanding of mental illness and its treatment. Treatment options for treatment resistant depression Sunday 23 July 12:00 – 16:45 Queen’s Suite 1 Chair – Allan Young, King’s College London

12:00 Lunch 13:00 – 13:15 Introduction Allan Young, King’s College London 13:15 – 13:45 ‘Standard’ medication options and when should non-standard options be considered? Hamish McAllister-Williams, Newcastle University 13:45 – 14:05 Medications targeting dopaminergic neurotransmission Alan Currie, Newcastle University 14:05 – 14:25 Running a ketamine treatment service in the NHS Rupert McShane, University of Oxford 14:25 – 14:45 Q&A with the Panel 14:45 – 15:15 Refreshments 15:15 – 15:35 tDCS Cindy Fu, King’s College London 15:35 – 15:55 TMS Michael Craig, King’s College London 15:55 – 16:15 VNS John Rush, Duke University 16:15 – 16:45 Q&A with the Panel 16:45 Refreshments www.bap.org.uk/BAP2017 March 2017 7 Launch of BAP Early Career Launch of the “Clinical Membership practice with anti-dementia As announced at the July 2016 AGM in Brighton, BAP drugs: A revised (third) has this month launched a new membership tier for Early Career scientists. consensus statement from Early Career Membership has been designed the British Association for to support early career scientists, such as post- doctorates, as well as clinical psychologist trainees Psychopharmacology” and medical doctors in clinical training posts or We were delighted to welcome 100+ attendees to the clinical junior training fellowships (with PhD Hallam Conference Centre in London in January to awarded). Those with university posts which are launch the most recent BAP guidelines. Sincere thanks below the status of Lecturer, such as research assistant to John O’Brien for leading the update of the guidelines or research associate shall also be considered. Early and putting together an excellent programme for the Career Membership is limited to a maximum 6-year day. The presenters were kept on their toes with lively term or until the Member attains a change in status and lengthy Q&A sessions, and shared a great rapport to Lecturer or completion of clinical training, during the panel discussions. Their enthusiasm and whichever is earliest. The annual subscription is 50% expertise was greatly appreciated by the audience. of the Full Membership fee, so currently £50. Date: 19 January / Presenters: John O’Brien, Alistair BAP Members whose status is affected by this Burns, Roy Jones, Peter Passmore, Ian McKeith, change have been contacted by the BAP Office. Alan Thomas, Clive Holmes, Gill Livingston, Louise Anyone with queries should contact Lynne Harmer Robinson, Liz Sampson at [email protected]. www.bap.org.uk/dementiaguidelines

BAP Consensus Guideline Buddy Scheme at the 2017 Statements Summer Meeting BAP Guidance on the use of psychotropic medication preconception, in pregnancy and postpartum is currently The BAP summer conference is a large very busy in press. Sincere thanks to Hamish McAllister- event which can seem quite daunting for newer Williams for his efforts to produce this substantial Training Members. This year, as part of our on- guideline, and to the other authors involved in the going initiative to increase support for our Training project. Members, the BAP will be offering a Conference Buddy scheme. This scheme, led by Dr Paul Stokes, We look forward to the publication in summer 2017 aims to match Training Members with experienced of BAP guidelines for the management of Autistic BAP members with similar research interests. The Spectrum Disorders, which will be explicitly evidence- Conference Buddy will organise an informal meeting based and valuable to clinicians. Thanks to Oliver with the trainee during the conference to provide an Howes and Declan Murphy for leading on the overview of the conference, discuss the best events production of those guidelines. for the trainee to attend, and may help the trainee to Both the Schizophrenia (led by Thomas Barnes) and identify appropriate people to network with during Insomnia (led by Sue Wilson) guidelines will be the conference. We hope that the Buddy scheme will reviewed in update meetings this year. allow informal mentoring relationships to further develop after the end of conference. Guidelines on Rapid Tranquilisation will be produced jointly with the National Association of Psychiatric Intensive Care and Low-Secure Units (NAPICU), with the first meeting held before summer 2017.

8 March 2017 BAP Session at the British Brain imaging study of cannabis Neuroscience Association dependence (Australia) Meeting, 10–13 April, A postdoctoral research fellow with experience and a part-time research assistant are Birmingham being sought for a new large scale study of neural characteristics underpinning cannabis dependence. Symposium 10: Microglia, The project is based in Australia within an neuroinflammation and psychiatric established team of cannabis researchers and UK disease: biomarkers and therapeutic and Dutch collaborators. Expressions of interest and requests for further information about this potential 4-year project may be addressed to Professor Tuesday 11th April, 9:00 – 10:40 Nadia Solowij: [email protected] or Dr Valentina Lorenzetti: [email protected]. Neuroinflammation and microglia are increasingly recognized as key players in psychiatric disorders. Early life events, such as maternal infection, have BAP Supporting Two Sessions been suggested to play a role in the aetiology of multiple psychiatric disorders. This symposium at the 2017 Cheltenham Science brings together experts from preclinical, clinical and industry perspectives to update us on the most Festival recent advances in this area; explaining how these advances will inform the development of biomarkers Big Data and Mental Health and novel therapeutic approaches. Thursday 8th June Chairs: From mood tracking apps and websites to digital Dr Paula Moran (University of Nottingham) and libraries of patient information, our individual Professor Carmine Pariante (Kings College London) behaviours are being collated and mapped, revealing startling new insights into mental illness. Psychiatrist and app developer John Geddes, psychiatric geneticist Microglia dynamics in the healthy and diseased brain Gerome Breen and data expert Sally McManus discuss Professor Hugh Perry (University of Southampton) how big data is helping to unravel the complexity of our mental wellbeing. Therapeutic modulation of microglia – opportunities and challenges Drugs and the Brain Dr Irene Knuesel (Roche, Switzerland) Saturday 10th June Biomarkers of inflammation and treatment response in psychosis and depression Whether it’s impacting visual perception or altering states of consciousness, drug use can drastically affect Professor Carmine Pariante brain states and behaviour. Psychologist and Say Why Genome-wide transcriptional profiling and structural to Drugs podcaster Suzi Gage is joined by psychedelics magnetic resonance imaging in the maternal immune researcher Robin Carhart-Harris, health psychologist activation model of neurodevelopmental disorders Sally Adams and journalist and novelist Lionel Shriver Dr Anthony Vernon (King College London) to discuss how different drugs affect the brain and to explore the positive and negative impacts of both legal and illegal substances. Summer Meeting Archive For more information go to: Previous summer meeting programmes and abstract www.cheltenhamfestivals.com/science books are now available on the website. www.bap.org.uk/summermeetingarchive

March 2017 9 BOOK REVIEW My Brain is Out of Control: Memoirs of a Doctor as a Patient by Dr Patrick Mbaya Peter Haddad

“I had a triple whammy: my illness and the two serious antibiotic complications of low white cell count and severe acute hepatitis’’

In this memoir Dr Patrick Mbaya, a consultant psychiatrist, gives a personal account of his diagnosis, treatment and recovery from a brain abscess and its complications including depression. What makes the book especially valuable is that it is written from the perspective of both a patient and a psychiatrist. It is divided into short chapters, each 1 to 3 pages in My Brain is Out of Control: Memoirs of a Doctor as a Patient length. Dr Mbaya frankly describes the impact of his Dr Patrick Mbaya illness on himself and his family. Medical concepts are explained using language and a style that is easy Publisher: AuthorHouse UK for a layperson to follow. For example, he explains Published: 2016 Pages: 56 ISBN: 9781524664190 how the position of his brain abscess led to the particular neurological symptoms he experienced, confused and paranoid. By then he had lost the ability that depression has been linked to reduced levels of to speak and so he sent a text to his GP asking for his noradrenaline and serotonin in the brain and how help in arranging his discharge. His GP immediately some drugs, in his case antibiotics, can occasionally texted back, explaining that he needed to remain in cause liver damage and a low white blood cell count. hospital and would get better. The story takes place in 2010 when Dr Mbaya was Some aspects of his early care were not ideal. A hospital 55 years old and working as an NHS consultant cleaner avoided him when it was queried that his psychiatrist. Until then he had never suffered from illness could be HIV related; a subsequent blood test any significant illness and as he explains ‘life revolved excluded HIV. A doctor questioned him insensitively around home and work’. He woke one morning to about whether he had used intravenous drugs, a find he had a mild right-sided facial weakness. nurse dismissed his concerns about medication side He and his GP assumed this was Bell’s palsy and effects and a speech therapist seemed to see him not particularly serious. An Ear, Nose and Throat primarily as an ‘unusual and very interesting’ case to (ENT) specialist he was referred to was of the same teach her juniors. Dr Mbaya reflects that some of opinion. He continued to work but his condition these memories could be coloured by his confusion quickly deteriorated with speech impairment, at the time. Nevertheless, his account highlights right sided weakness, unsteadiness and emotional the importance of health care professionals being lability appearing. This culminated in an emergency empathic and treating patients with respect. admission to a local hospital where he briefly became

10 March 2017 After three days in hospital, a brain abscess was there, commenting ‘the ward felt like a community diagnosed and he was urgently transferred to in a supportive and caring environment where everyone a regional neurosurgery unit where he was an did their bit’. He was apprehensive when he was inpatient for four weeks. In his book, Dr Mbaya discharged home. explains that a brain abscess (also termed a cerebral Following discharge, he gradually recovered despite abscess) is a collection of infected material within setbacks and frustrations. His speech and energy the brain. It can arise as a complication of a nearby levels slowly improved. He kept a daily record or a distant infection in the body, for example an ear of events after his operation. He found writing infection or a chest infection respectively. It can also therapeutic as it gave him a purposeful activity and be a complication of a skull fracture but in about 10% helped him to channel his emotions. Later he referred of cases, as with himself, the source of the infection to these notes when writing his book. After five is never identified. Even with modern treatment months, he returned to work on a graded basis but about one out of ten people with a brain abscess looking back reflects that this was probably too soon. die and some of those who survive are left with a Driving regulations require that anyone who has had disability. The day after his transfer, he underwent a brain abscess must inform the Driving and Vehicle an operation to reduce raised intracranial pressure, Licensing Agency (DVLA) of their condition and not drain the abscess and identify the bacteria involved. drive for a minimum of 12 months. Regaining his For the first two weeks after surgery he could hardly driving license was an important milestone as it gave speak, could not write and needed to communicate him greater independence. He concludes that he was by texting with his non-dominant hand. His very fortunate to eventually make a full recovery. A recovery after surgery was not straightforward. He strong theme is how the support of others, primarily developed a low white blood cell count and hepatitis his wife and two grown up children, helped him. It is (inflammation of the liver), side effects from two also clear that despite his condition being potentially different intravenous antibiotics that he received. life threatening, he maintained a positive outlook Immediately prior to his operation, Dr Mbaya and a determination to recover throughout. realised that he was suffering from depression. This is an excellent book that will be of value to He experienced low mood, tearfulness, low self- anyone who wants to gain a better understanding confidence and negative thinking, even worrying at of what it is like to experience a brain disorder such one point that through his illness he had disgraced as an abscess, stroke or encephalitis. The author’s his family. These symptoms were worse in the description of his emotional and physical symptoms mornings. His mental state improved significantly shows how the boundary between neurological and following surgery but his mood remained low. He psychiatric illness is often blurred. His positive considered antidepressant treatment but instead outlook through adversity, and his recovery, make it opted to manage his depression through distraction, an inspiring account that should give hope to patients including listening to music and visiting a hospital and families dealing with similar illnesses. I also garden, trying to think positively and where possible recommend this book to health care professionals so gain a sense of control over his situation. that they can better appreciate illness and health care He quickly became accustomed to the routine on the from a patient perspective. Dr Mbaya is a long-term neurosurgical ward with its regular times for blood friend and colleague of mine. As such it has been a tests, administration of medicines and meals. He particular pleasure to review this book. is complementary of the staff and care he received

DON’T FORGET Deadlines for summer meeting submissions are coming up – 27th March for abstracts and bursary applications, and 24th April for undergraduate abstracts

March 2017 11 Media Activities A showcase for the media and public engagement activities of BAP members. Following are some of the latest media activity over the past few months. All media activities, with links, can be found at www.bap.org.uk/media HipHopPsych (Akeem Sule and Becky Inkster) Ravi Das 24th January 2017 3rd January 2017 Radical ketamine therapy The last barrier that fell in could treat alcohol Hip Hop addiction Hiphoppsych are Ravi Das is leading a study interviewed by Chilean into using ketamine to newspaper La Tercera help alcohol addiction with various media coverage

Andrew Mayers 10th January 2017 Mental health charity Stephen Lawrie 1st February 2017 welcomes Theresa May’s Why schizophrenia need reforms – but says ‘staff not rob us of a life in need more than retraining’ academia Andrew is interviewed Stephen is interviewed by by Bournemouth Echo regarding in response to the Prime Minister’s statement on working in academia with mental health a mental illness

Natalia Lawrence 17th January 2017 Andrew Mayers 16th February 2017 How to Lose Weight Well Unexpected deaths of Natalia appeared on mental health patients Channel 4’s “How to Lose in Dorset up 50% in three Weight Well”. She also years released an food training Andrew is interviewed by app which has featured in Bournemouth Echo about and the Telegraph increases in unexpected deaths related to mental health

Matt Wall 23rd January 2017 Carmine Pariante 21st February 2017 Kisspeptin modulates Antidepressants may not sexual and emotional brain be perfect, but they DO processing in humans save lives Matt published a paper on Carmine writes for the the brain effects of the sex Daily Mail showing how, hormone Kisspeptin with when used correctly, various media coverage antidepressants do work Have you recently engaged with the public in science via the media or public events? Please send any links or other engagement with the 12 March 2017 media to Sarah Channing-Wright ([email protected]). Education Events

Certificate in Clinical Psychopharmacology

Overview Forthcoming Modules Psychopharmacology is the single most 4th May 2017 – commonly used treatment modality in Schizophrenia Manchester 5th May 2017 psychiatry. It is vital we use drugs to their optimal effect – matching our choices Drug Treatments in 28th September 2017 – Newcastle and regimes to the needs and symptoms Affective Disorders 29th September 2017 of patients whilst minimising side Drug Treatments in 19th October 2017 – effects and avoiding adverse interactions Newcastle with other drugs. New drugs and new Old Age Psychiatry 20th October 2017 ways of using old ones regularly appear. Child and Adolescent 16th November 2017 – With ever increasing demands on our Newcastle Psychopharmacology 17th November 2017 professional time it is difficult to keep up to date. This programme for CPD in 7th December 2017 – Substance Misuse Manchester state-of-the-art psychopharmacology is 8th December 2017 tailored to emphasise practical everyday 25th January 2018 – problems encountered by all prescribing Anxiety Disorders Bristol psychiatrists. 26th January 2018

Content includes: Registration fees ʍʍ lectures £390 per 1.5 day module ʍʍ workshops To book a place go to www.bap.org.uk/certificate ʍʍ discussion sessions

Masterclasses in Clinical Psychopharmacology Forthcoming modules

Overview Schizophrenia 22 November 2017 The Masterclasses are held over three Day A Substance 25 April 2018 consecutive days, twice a year. You can Misuse 21 November 2018 register for one, two or all three days, Hallam depending on your needs and interests. Bipolar Conference 23 November 2017 The full three day package is intended Perinatal Centre Day B 26 April 2018 to provide a state-of-the-art update in ADHD 44 Hallam Street 22 November 2018 psychopharmacology for clinicians. London W1W 6JJ Depression 24 November 2017 Content includes: Anxiety Day C 27 April 2018 ʍʍ a review of the basic pharmacology Sleep 23 November 2018 of the relevant drugs ʍʍ the clinical use of those drugs Registration fees ʍʍ discussions around relevant BAP and NICE guidelines £330 per day, £890 for all three days ʍʍ questions and discussion with the To book a place go to www.bap.org.uk/masterclasses speakers March 2017 13 ONLINE CPD RESOURCE A high quality, up-to-date resource taught by top experts in their field

Schizophrenia Substance Misuse Including Comorbidity Bipolar Disorder Perinatal Disorders ADHD Focussing On Adult Depression Anxiety Disorders Sleep Old Age £120 Child and Adolescent per year General Psychopharmacology non-members

Reviews of recent psychopharmacology papers, regularly updated PLUS £60 Multiple Choice Questions, printable certificate per year on completion and reading lists members and those who have registered or attended recent BAP meetings/courses

Also available on iPad £45 per year multiple users (10+)

For more information and to subscribe go to www.bap.org.uk/onlinecpd £30 per year RCPsych CPD subscribers

14 March 2017 TODAY’S SCIENCE TOMORROW’S MEDICINES New: UNDERGRADUATE PHARMACOLOGY CORE CURRICULUM A fundamental aim of the British Pharmacological It is freely available on the Society website for Society is to ‘promote and encourage the education use by educators, employers and students to and training of pharmacologists’. To meet the identify the core knowledge, skills and attitudes of challenge of a changing global scientifi c landscape, Pharmacology undergraduates. The curriculum is pharmacology must be a responsive discipline, not intended to be overly prescriptive and should producing graduates who can innovate and adapt. be read in conjunction with the QAA Benchmark Statement for Biomedical Sciences. Educators This new core curriculum will inform should use their own academic judgement, undergraduate Pharmacology programmes experience, resources, and knowledge of their and help educators nurture the graduates of students’ needs in interpreting the curriculum and the future. applying it to their programmes. To access the new curriculum, please visit www.bps.ac.uk/UGcore

If you’d like to discuss the core curriculum, or work more closely with the Society on pharmacology education, please contact the Education, Training & Policy Team on [email protected].

Register & submit your research IN SILICO & IN VITRO METHODS IN MODERN DRUG DISCOVERY 24 – 25 April 2017 Nottingham, UK

The rate of entry of new drugs into the clinic has slowed alarmingly and new, more e‡ cient discovery strategies are needed. Exciting Dates for your diary opportunities can be realised by improving the use of in silico and Abstract submission deadline: 21 Mar 2017 in vitro techniques. Member bursary deadline: 21 Mar 2017

This focused meeting has been organised by the British Early-bird registration deadline: 31 Mar 2017 Pharmacological Society to bring together academic and industrial Final registration deadline: 13 Apr 2017 scientists and students aspiring to work in drug discovery to discuss novel approaches to developing new medicines.

For more information about attending or presenting please contact [email protected] or visit www.bps.ac.uk/modern

www.bps.ac.uk March 2017 15 Get involved with 2017: The Physiology of Stress Let us help promote your research; collaborate with us by joining our media, policy and public engagement activities. Email [email protected] for funding opportunities and more.

Why come to BNA2017? #YearOfStress

CMHP Annual International Psychiatric Why come to BNA2017? Pharmacy Conference  This flagship meeting of the British Neuroscience Association is a major, international, cross-disciplinary celebration of neuroscience! We are pleased to announce that bookings are now We welcome delegates  Six plenary lectures by internationally recognised speakers including 2016 Brain Prize winner, Graham being taken for our 8th International Conference, from around the Collingridge, and 2014 Nobel Prize winner, May-Britt Moser which will be held at The Midland, Manchester from world. A highlight  Over 40 symposia, workshops & special events Friday 13 October to Sunday 15 October 2017. of the conference is  750 posters plus rapid-fire poster talks session and poster prizes always the Brett Hill Our theme this year is 'A Wider Perspective'. We  Publication of abstracts in Gold Open Access scientific journal will be looking at how mental health can be affected Memorial Lecture. For  200 speakers from across the world by outside influences such as physical health. Our this lecture we invite conference is the flagship event in our calendar. speakers with lived experience of mental health  12 scientific themes We provide delegates with opportunities to explore problems to share their insights with us. Topics  Discussion forums on public engagement; neuroscience post-Brexit; reproducibility; and scientific publishing clinical and strategic issues, to share good practice, can be varied, but this session is usually moving, to learn from each other and to enable networking. informative and highly valued by delegates.  Sessions specifically for early-career researchers, including the popular ‘Speed- dating for careers in science’ Our conference programme is designed to inspire, For more information, or to book your place, please visit  World-class conference centre in the UK’s second city of Birmingham, a stone’s throw from ‘Shakespeare country’ educate and enthuse. We invite eminent speakers to the conference page: www.kc-jones.co.uk/cmhp2017 deliver keynote sessions, and we offer a mix of plenary Members of BAP are eligible to apply for the members'  Exciting public engagement programme sessions, workshops, presentations and poster sessions. discount to attend the event. Register now to take  Social events including Welcome Reception, Student Games Night and the Brain Prize event Through these, we aim to gain insight into the latest advantage of the early bird discount!  Reduced fees for members of all participating societies developments in mental health pharmacy, and to share  A major trade exhibition with ~65 exhibitors good practice. In addition, we host a medical exhibition which can be visited during breaks and over lunch. Hurry, register soon!

16 March 2017 www.bna2017.org

Why come to BNA2017?

Why come to BNA2017?

 This flagship meeting of the British Neuroscience Association is a major, international, cross-disciplinary celebration of neuroscience!  Six plenary lectures by internationally recognised speakers including 2016 Brain Prize winner, Graham Collingridge, and 2014 Nobel Prize winner, May-Britt Moser  Over 40 symposia, workshops & special events  750 posters plus rapid-fire poster talks session and poster prizes  Publication of abstracts in Gold Open Access scientific journal  200 speakers from across the world  12 scientific themes  Discussion forums on public engagement; neuroscience post-Brexit; reproducibility; and scientific publishing  Sessions specifically for early-career researchers, including the popular ‘Speed- dating for careers in science’  World-class conference centre in the UK’s second city of Birmingham, a stone’s throw from ‘Shakespeare country’  Exciting public engagement programme  Social events including Welcome Reception, Student Games Night and the Brain Prize event  Reduced fees for members of all participating societies  A major trade exhibition with ~65 exhibitors Hurry, register soon!

www.bna2017.org March 2017 17